These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37738592)

  • 61. The current role of cannabis and cannabinoids in health: A comprehensive review of their therapeutic potential.
    Coelho MP; Duarte P; Calado M; Almeida AJ; Reis CP; Gaspar MM
    Life Sci; 2023 Sep; 329():121838. PubMed ID: 37290668
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Delta-What? Deciphering the World of Cannabinoids.
    Volpe K; Wightman RS
    R I Med J (2013); 2022 Sep; 105(7):37-41. PubMed ID: 36041020
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Implications of Cannabis and Cannabinoid Use in COVID-19: Scoping Review.
    Pereira CF; Vargas D; Toneloto FL; Ito VD; Volpato RJ
    Rev Bras Enferm; 2022; 75Suppl 1(Suppl 1):e20201374. PubMed ID: 35262598
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been ….
    Baron EP
    Headache; 2015 Jun; 55(6):885-916. PubMed ID: 26015168
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cannabis and Inflammatory Mediators.
    Lima MG; Tardelli VS; Brietzke E; Fidalgo TM
    Eur Addict Res; 2021; 27(1):16-24. PubMed ID: 32726782
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Anti-inflammatory Potential of Terpenes Present in
    Downer EJ
    ACS Chem Neurosci; 2020 Mar; 11(5):659-662. PubMed ID: 32091871
    [No Abstract]   [Full Text] [Related]  

  • 67. Co-exposure of cocaine and cannabinoids and its association with select biological, behavioural and health outcomes: A systematic scoping review of multi-disciplinary studies.
    Daldegan-Bueno D; Maia LO; Glass M; Jutras-Aswad D; Fischer B
    Eur Neuropsychopharmacol; 2021 Oct; 51():106-131. PubMed ID: 34273801
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Antinociceptive effects of minor cannabinoids, terpenes and flavonoids in Cannabis.
    Rodriguez CEB; Ouyang L; Kandasamy R
    Behav Pharmacol; 2022 Apr; 33(2&3):130-157. PubMed ID: 33709984
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Is Cannabis of Potential Value as a Therapeutic for Inflammatory Bowel Disease?
    Naftali T
    Dig Dis Sci; 2019 Oct; 64(10):2696-2698. PubMed ID: 31388856
    [No Abstract]   [Full Text] [Related]  

  • 70. Cannabinoids for the Treatment of Opioid Use Disorder: Where is the Evidence?
    Suzuki J; Weiss RD
    J Addict Med; 2021 Apr; 15(2):91-92. PubMed ID: 32909980
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Knowledge, Perception, and Use of Cannabis Therapy in Patients with Inflammatory Bowel Disease.
    Muñiz-Camacho LA; Negrón-Quintana FI; Ramos-Burgos LA; Cruz-Cruz JJ; Torres EA
    P R Health Sci J; 2021 Sep; 40(3):110-114. PubMed ID: 34792923
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cannabinoids: for better and for worse
.
    Thibaut F; Hoehe MR
    Dialogues Clin Neurosci; 2020 Sep; 22(3):201-204. PubMed ID: 33162763
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cannabis and Cannabinoids in Multiple Sclerosis: From Experimental Models to Clinical Practice-A Review.
    Sirbu CA; Georgescu R; Pleşa FC; Paunescu A; Marilena Ţânţu M; Nicolae AC; Caloianu I; Mitrica M
    Am J Ther; 2023 May; 30(3):e220-e231. PubMed ID: 37278703
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Inflammatory bowel disease and cannabis: key counseling strategies.
    Saidman J; Rubin S; Swaminath A
    Curr Opin Gastroenterol; 2023 Jul; 39(4):301-307. PubMed ID: 37144523
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The therapeutic effects of Cannabis and cannabinoids: An update from the National Academies of Sciences, Engineering and Medicine report.
    Abrams DI
    Eur J Intern Med; 2018 Mar; 49():7-11. PubMed ID: 29325791
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cannabis in Parkinson's Disease - the patient's perspective versus clinical trials: a systematic literature review.
    Figura M; Koziorowski D; Sławek J
    Neurol Neurochir Pol; 2022; 56(1):21-27. PubMed ID: 34985112
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The Psychiatric Consequences of Cannabinoids.
    De Aquino JP; Sherif M; Radhakrishnan R; Cahill JD; Ranganathan M; D'Souza DC
    Clin Ther; 2018 Sep; 40(9):1448-1456. PubMed ID: 29678279
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cannabinoids: A Guide for Use in the World of Gastrointestinal Disease.
    Unal E; Anderson B; Helber A; Marks JH
    J Clin Gastroenterol; 2020 Oct; 54(9):769-788. PubMed ID: 31789770
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Role of Cannabinoids in Various Diseases: A Review.
    Kaur S; Sharma N; Roy A
    Curr Pharm Biotechnol; 2022; 23(11):1346-1358. PubMed ID: 34951355
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Symptoms and Extraintestinal Manifestations in Active Cannabis Users with Inflammatory Bowel Disease.
    Coates MD; Dalessio S; Walter V; Stuart A; Bernasko N; Tinsley A; Razeghi S; Williams ED; Clarke K; Vrana K
    Cannabis Cannabinoid Res; 2022 Aug; 7(4):445-450. PubMed ID: 33998892
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.